Delight Dermatology Clinic symbol logo
غانغنام، سيول
Delight Dermatology

ساعات العمل والموقع

الاثنين - الجمعة 10:00 - 20:00

السبت 10:00 - 16:00

غانغنام، سيول

JUVELOOK Volume Treatment in Seoul — Collagen-Biostimulating Volume · PDLLA + HA

Collagen-Biostimulating Volume · PDLLA + HA

JUVELOOK Volume Treatment in Seoul

JUVELOOK Volume (sold internationally as LENISNA) is a PDLLA + HA collagen-biostimulating injectable for facial volume loss — cheeks, mid-face, and nasolabial folds. It carries roughly 4× the PDLLA dose of base JUVELOOK for deeper volumization, pairing same-day HA support with gradual collagen build over months. It is MFDS-approved in Korea and CE-marked, but NOT FDA-approved. A dermatologist consultation confirms suitability, and individual results vary.

طبيب جلدية معتمد

Board-Certified

زميل دولي AAD

IFAAD

أجهزة معتمدة من FDA

حسب الإجراء

مسجل لدى MFDS

وزارة الصحة الكورية

د. يون سانغ يول
مراجعة طبية بواسطة د. يون سانغ يول
طبيب جلدية معتمد · المدير الرئيسي · عضو AAD
01

نظرة عامة

JUVELOOK Volume in Seoul — PDLLA + HA collagen-biostimulating injectable for cheek hollowing, mid-face volume loss, and nasolabial folds. MFDS-approved, not FDA-approved.

مناسب لهذه المخاوف

  • Cheek hollowing and mid-face volume loss
  • Nasolabial folds and soft facial contour
  • Tired, flat, or aged appearance from deflation
  • Patients preferring gradual, natural volume over immediate filler

الفئة الموصى بها

  • Patients with mild-to-moderate facial volume loss wanting a natural, gradual change
  • Those preferring collagen-biostimulating volume over immediate HA filler
  • Patients ready for a 2-3 session course at about 1-month intervals
  • Patients wanting honest regulatory disclosure (MFDS / CE, not FDA)
المدة

20-40 min

الجلسات

2-3 at about 1-month intervals

فترة التعافي

Minor (resolves in a few days)

ذروة النتيجة

3-6 months (collagen remodeling)

02

مراحل النتائج

  1. Same day

    Mild swelling, redness, tenderness, or small injection marks. Early volume/hydration effect is not the final result.

  2. Days 1-7

    Swelling or bruising gradually improves; the area may feel slightly firm or uneven temporarily.

  3. Weeks 4-8

    Collagen stimulation becomes more noticeable — subtle firmness, texture, and soft volume support.

  4. Months 3-6

    Gradual collagen change becomes more visible; facial volume and elasticity look more naturally improved.

  5. Months 12-24

    Maintenance timing varies; a follow-up session may be considered per skin condition and goals.

03

الأجهزة المستخدمة

JUVELOOK Volume PDLLA + HA collagen biostimulator

JUVELOOK Volume (VAIM PDLLA + HA, intl. LENISNA)

VAIM Co., Ltd. (Korea)MFDS-approved (Korea), CE-marked (EU). NOT FDA-approved.

المواصفات الرئيسية

Active
PDLLA microspheres + HA carrier (about 4× PDLLA dose of base JUVELOOK)
Mechanism
HA same-day support + PDLLA collagen build over months
Placement
deep dermis or subcutaneous, per treatment area
Course
2-3 sessions at about 1-month intervals
Cannula for periorbital and other high-risk zones
Restoration effect typically observed from around 6 weeks
04

سير الإجراء

  1. 01

    Dermatologist evaluates facial structure, skin quality, volume loss, and goals — confirming suitability or a better route

  2. 02

    Areas are mapped around facial balance (cheeks, mid-face, nasolabial folds), not simply adding volume

  3. 03

    After cleansing, JUVELOOK Volume is injected in the deep dermis or subcutaneous layer per area

  4. 04

    Session takes about 20-40 minutes; guidance on swelling and follow-up timing is provided

  5. 05

    A 2-3 session course at about 1-month intervals is typical, adjusted to response

الحقن وأجهزة الطاقة يُجريها الأطباء بأنفسهم، ولا تُفوَّض أبداً للممرضين أو الفنيين. ويقود العيادة طبيب جلدية معتمد.

د. سانغ يول يون · مدير العيادة · طبيب جلدية معتمد · AAD International Fellow
05

العناية بعد الإجراء

  1. First 24 hours

    Avoid touching, pressing, or rubbing the area. Skip heavy exercise, alcohol, sauna, hot baths, and strong heat. Mild swelling or tenderness may occur.

  2. Days 1-3

    Bruising or swelling may become more noticeable before improving. Gentle skincare and sunscreen. Contact the clinic for severe pain or unusual discoloration.

  3. Week 1

    Most temporary injection-related reactions improve within several days. Do not massage the area unless your dermatologist instructs it.

  4. Long-term

    Maintain sunscreen and a gentle routine. Collagen results are gradual — assess over time. Follow-up sessions may be recommended per your plan.

06

الأسئلة الشائعة

Is JUVELOOK Volume the same as a filler, or FDA-approved?

It differs from a traditional HA filler. While HA fillers mainly create immediate volume by filling space, JUVELOOK Volume combines HA with PDLLA to support gradual collagen stimulation, so the final result develops more slowly and naturally. Regulatory status: it is MFDS-approved in Korea and CE-marked, but NOT FDA-approved as an injectable in the US.

How is JUVELOOK Volume different from base JUVELOOK?

Same active ingredients (PDLLA + HA), different formulation. Base JUVELOOK uses smaller particles for superficial-to-mid-dermal skin boosting (texture, fine lines). JUVELOOK Volume — sold internationally as LENISNA — has roughly 4× higher PDLLA dose and a thicker HA carrier for deep-dermal or subcutaneous volumization of the mid-face, cheeks, and folds.

When will I see results, and how many sessions are needed?

Some early change may show soon from the HA component, but collagen-related improvement develops gradually — often noticeable around 4-8 weeks, with more visible change around 3-6 months. Many patients are advised 2-3 sessions at about 1-month intervals; the ideal number depends on volume loss, treatment area, and goals, set after consultation.

What are the most serious risks?

Rare but serious: vascular occlusion (including visual complications) from inadvertent intravascular injection, particularly in glabellar, periorbital, and forehead zones. The Asia-Pacific PDLLA-HA vascular-safety consensus guides safe technique — cannula for high-risk zones, hyaluronidase emergency kit, and anatomy-based depth control. Common transient risks include swelling, bruising, and mild redness; rare late-onset nodules have been documented and are manageable.

تنبيهات وموانع الاستعمال

يُرجى إبلاغ الطبيب أثناء الاستشارة إذا انطبق عليك أي مما يلي. قد يتعذّر إجراء العلاج أو يتطلب تعديل الخطة.

  • سنبلغك بموانع الاستعمال بالتفصيل خلال الاستشارة قبل العلاج.

إرشادات لزيارتك

  • Mild swelling or bruising usually resolves within a few days; bruising can take longer in some patients
  • Full course is about 2-3 sessions at 1-month intervals — short-trip patients complete one session and continue later
  • Avoid heat and exercise 24-48h; collagen-driven change develops over 3-6 months after departure
07

المراجع

المعلومات الطبية الواردة في هذه الصفحة — بما في ذلك مواصفات الأجهزة ومراحل الفعالية وخصائص السلامة — مستندة إلى المصادر الأولية أدناه. يرتبط كل مرجع بالدراسة الأصلية أو السجل التنظيمي المعني.3 refs
  1. [1]Hybrid PDLLA-HA for Tear Trough Rejuvenation. Aesthetic Plast Surg (Young & Lau) — prospective PDLLA-HA study N=15 (2026).
  2. [2]Safe Injection Technique for PDLLA-HA200 (Visual Impairment Consensus). J Craniofac Surg (Lau et al.) — authoritative PDLLA-HA vascular-safety consensus (2025).
  3. [3]PLLA vs PDLLA Fillers: Comparative Mouse Study. In Vivo (Jang et al.) — independent SNU/Sookmyung PLLA vs PDLLA comparator (2026).
مراجعة طبية بواسطةDr. SangYoul Yun· Board-Certified Dermatologist · AAD International Fellow (IFAAD)· آخر مراجعة 2026-07-14

إجراءات ذات صلة

ملاحظة: قد تختلف النتائج حسب حالة البشرة وتاريخ العلاج وعوامل التعافي. يتم تحديد جميع خطط العلاج من خلال استشارة طبيب جلدية معتمد. المعلومات في هذه الصفحة للاستدلال فقط ولا تشكل نصيحة طبية أو ضمان نتائج محددة.

الخطوة التالية

يمكنك البدء برسالة قصيرة قبل أن تقرر بشأن JUVELOOK Volume.

يكفي أن تتأكد أولًا مما إذا كان هذا العلاج مناسبًا لك، وهل يلائم وقتك، وما العلاج الذي ينبغي التفكير فيه أولًا.